Inscripta
Inscripta, Inc. is a gene editing technology company based in Boulder, Colorado, with additional offices in Pleasanton and San Diego, California. Founded in 2015, Inscripta focuses on developing CRISPR enzymes, specifically MADzymes, for precision gene editing. The company has created a benchtop platform for scalable digital genome engineering, which includes an instrument, consumables, software, and assays that facilitate a fully automated workflow. This platform allows for massively parallel and trackable editing of single cells, significantly enhancing the scale and efficiency of gene editing research. By making its MAD7 CRISPR nuclease freely available for research and development, Inscripta aims to remove existing technical and licensing barriers, thereby empowering scientists and fostering a new era of biological discovery.
Top Stages
3 past transactions
Sestina Bio
Acquisition in 2023
Sestina Bio, LLC, established in 2020 and headquartered in Delaware, is a biotechnology company dedicated to addressing global challenges through innovative synthetic biology solutions. The company's mission is to create an advanced research and development platform that integrates cutting-edge technologies such as synthetic biology, data sciences, and bio-analytical systems. Sestina Bio specializes in engineering yeast and bacteria to produce chemicals and pharmaceuticals using its proprietary genome editing tools, single-cell biology techniques, and machine learning algorithms.
Infinome Biosciences
Acquisition in 2023
Infinome Biosciences is a pioneering synthetic biology company focused on bioengineering solutions. The company has developed a platform that aims to unlock the vast potential of the genome, facilitating the optimization of commercial biomanufacturing systems. By streamlining these processes, Infinome enables faster and more cost-effective development of new biobased manufacturing methods. This innovation enhances researchers' ability to create robust and efficient solutions for optimizing industrial enzyme performance, ultimately accelerating advancements in the field of biotechnology.
Solana Biosciences
Acquisition in 2018
Solana Biosciences is a life sciences company focused on providing innovative solutions in the field of biotechnology. The firm specializes in sales leads and sales intelligence data, facilitating the launch and production of a diverse array of products. Notably, it has developed a market-leading DNA sequencing service, positioning itself as a key player in the life sciences sector. Through its expertise, Solana Biosciences aims to advance research and development in biotechnology, supporting scientific progress and enhancing product offerings in the industry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.